NEW YORK, March 22, 2017 -- Sequential Brands Group, Inc. (Nasdaq:SQBG) (the “Company”) today announced that Karen Murray has been appointed Chief Executive Officer of the Company. Ms. Murray has also been appointed to serve as a Director of the Company. A strong operator who has a depth of management and industry experience, she was most recently President of VF Sportswear, a wholly owned subsidiary of VF Corporation, one of the world’s largest apparel makers. Ms. Murray is replacing Yehuda Shmidman, who is stepping down from his position at the Company and as a member of the Board of Directors.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c16dcf66-e126-4185-aac3-408bd41200a0
William Sweedler, Chairman of the Board said, “Karen Murray has outstanding leadership skills and industry experience and she has demonstrated her ability to activate and grow successful brands. We are excited to have an executive of Karen’s caliber join and lead our team at Sequential to grow with us. I have admired her and watched her thrive in her career, and I am pleased that we will be able to work together.”
“I’m excited to join Sequential Brands Group, a company with powerful brands, world-class licensing and retail partners, and a talented team,” said Ms. Murray. “After 30 years of experience managing consumer brands in both licensing and operating businesses, I’m thrilled to join a company with such strong growth prospects, and I look forward to working with the team.”
Prior to joining Sequential, Ms. Murray was the President of VF Sportswear, where she oversaw the $1.2 billion global brand, Nautica, as well as Kipling. She joined VF Sportswear, in 2007 as President of its Nautica Men's Sportswear and Nautica Jeans Company businesses and the following year, she was appointed President of VF Sportswear. Ms. Murray began her career at Gant, where she remained for nine years before transitioning to Liz Claiborne. She assumed many different roles throughout her tenure at Claiborne, including President from 1998 to 2007.
“On behalf of the Board, I want to thank Yehuda for his service and the contributions he has made during his tenure with the Company,” continued Sweedler. “We wish him the best in his future endeavors.”
About Sequential Brands Group, Inc.
Sequential Brands Group, Inc. (Nasdaq:SQBG) owns, promotes, markets, and licenses a portfolio of consumer brands in the fashion, active and home categories. Sequential seeks to ensure that its brands continue to thrive and grow by employing strong brand management, design and marketing teams. Sequential has licensed and intends to license its brands in a variety of consumer categories to retailers, wholesalers and distributors in the United States and around the world. For more information, please visit Sequential’s website at: www.sequentialbrandsgroup.com. To inquire about licensing opportunities, please email: [email protected].
For media inquiries, contact: Magrino Leigh Ann Ambrosi/ Mary Blanton Ogushwitz T: 212-672-0353/212-259-0534 E: [email protected] / [email protected] For Investor Relations inquiries, contact: Sequential Brands Group, Inc. Katherine Nash T: 512-757-2566 E: [email protected]


Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 



